Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed earnings per share (EPS) estimates for FY23-24.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 42%
While bulls were a confident lot after the election results, with every trading session they are once again moving to take control of every corner